《大行報告》大摩:網易(NTES.US)6月發布四款遊戲 料第三季收入創新高
大摩發表報告指,網易(NTES.US)今個月將發布四款遊戲,可能推動第三季遊戲收入創新高。目前市場預測主要反映《正義行動》,而其他遊戲推出將推動每股盈利上升。現價相當於今年預測市盈率14-15倍,估值仍然吸引,該行重申網易是其首選,目標價120美元,評級「增持」。
大摩料網易遊戲收入第三季按年增長16%、按季增11%,達到201億人民幣,創新高。其中,手遊收入按年增長25%,達到149億人民幣。
大摩提到,網易的營運利潤增長已經連續七個季度超過遊戲收入的增長,預計利潤率將繼續穩步提升,主要是由完善支付渠道、終止利潤率較低的暴雪遊戲和非遊戲部門虧損收窄所推動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.